Mira Biotech (Series A)
Funding Details
Date Award
September 30, 2023
Vertical
Biotech
Funding URL
View Funding Page
Valuation
$65,200,000
Funding Amount
$8,500,000
Company Info
Founding Year
2018
Traction
Mira Biotech has successfully completed preclinical studies and is preparing for clinical trials. They have secured partnerships with leading research institutions and pharmaceutical companies to advance their pipeline.
Organizations Involved
Sequoia Capital, Andreessen Horowitz, UCSF, Genentech
Founders
Emily Chen, Michael Lee
Market
Healthcare
Location
San Francisco, CA, US
Coinvestors
Sequoia Capital, Andreessen Horowitz
Company Description

Mira Biotech is a biotechnology company focused on developing innovative therapies for various diseases. Their proprietary technology platform enables the rapid discovery and development of novel treatments, with a current focus on oncology and rare genetic disorders. By leveraging cutting-edge research and strategic partnerships, Mira Biotech aims to address unmet medical needs and improve patient outcomes.

Links
Website
Back to HomeBack to Biotech DealsView Funding Announcement